Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Promoting vaccination in maternity wards ─ motivational interview technique reduces hesitancy and enhances intention to vaccinate, results from a multicentre non-controlled pre- and post-intervention RCT-nested study, Quebec, March 2014 to February 2015.

Gagneur A, Battista MC, Boucher FD, Tapiero B, Quach C, De Wals P, Lemaitre T, Farrands A, Boulianne N, Sauvageau C, Ouakki M, Gosselin V, Petit G, Jacques MC, Dubé È.

Euro Surveill. 2019 Sep;24(36). doi: 10.2807/1560-7917.ES.2019.24.36.1800641.

2.

Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling study.

Drolet M, Zhou Z, Sauvageau C, DeWals P, Gilca V, Amini R, Bénard É, Brisson M.

CMAJ. 2019 Aug 26;191(34):E932-E939. doi: 10.1503/cmaj.190274.

3.

A mixed vaccination schedule of HPV vaccine induces a 100% seropositivity to all 9 HPV types included in 9vHPV vaccine.

Gilca V, Sauvageau C, De Serres G.

Vaccine. 2019 Jul 26;37(32):4422-4423. doi: 10.1016/j.vaccine.2019.06.028. No abstract available.

PMID:
31319931
4.

Long intervals between two doses of HPV vaccines and magnitude of the immune response: a post hoc analysis of two clinical trials.

Gilca V, Sauvageau C, Panicker G, De Serres G, Schiller J, Ouakki M, Unger ER.

Hum Vaccin Immunother. 2019;15(7-8):1980-1985. doi: 10.1080/21645515.2019.1605278. Epub 2019 Jun 3.

PMID:
31017850
5.

Promoting vaccination in the province of Québec: the PromoVaQ randomized controlled trial protocol.

Gagneur A, Quach C, Boucher FD, Tapiero B, De Wals P, Farrands A, Lemaitre T, Boulianne N, Sauvageau C, Ouakki M, Gosselin V, Gagnon D, Petit G, Jacques MC, Dubé È.

BMC Public Health. 2019 Feb 6;19(1):160. doi: 10.1186/s12889-019-6468-z.

6.

Challenges and opportunities of school-based HPV vaccination in Canada.

Dubé E, Gagnon D, Clément P, Bettinger JA, Comeau JL, Deeks S, Guay M, MacDonald S, MacDonald NE, Mijovic H, Paragg J, Rubincam C, Sauvageau C, Steenbeck A, Wilson S; Canadian Immunization Research Network.

Hum Vaccin Immunother. 2019;15(7-8):1650-1655. doi: 10.1080/21645515.2018.1564440. Epub 2019 Feb 20.

PMID:
30633622
7.

Impact of vaccine delays at the 2, 4, 6 and 12 month visits on incomplete vaccination status by 24 months of age in Quebec, Canada.

Kiely M, Boulianne N, Talbot D, Ouakki M, Guay M, Landry M, Sauvageau C, De Serres G.

BMC Public Health. 2018 Dec 11;18(1):1364. doi: 10.1186/s12889-018-6235-6.

8.

Herpes Zoster Burden in Canadian Provinces: A Narrative Review and Comparison with Quebec Provincial Data.

Letellier MC, Amini R, Gilca V, Trudeau G, Sauvageau C.

Can J Infect Dis Med Microbiol. 2018 Oct 21;2018:3285327. doi: 10.1155/2018/3285327. eCollection 2018. Review.

9.

Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine - A randomized clinical trial.

Gilca V, Sauvageau C, Panicker G, De Serres G, Ouakki M, Unger ER.

Vaccine. 2018 Nov 12;36(46):7017-7024. doi: 10.1016/j.vaccine.2018.09.057. Epub 2018 Oct 9.

PMID:
30314913
10.

Antibody persistence after a single dose of quadrivalent HPV vaccine and the effect of a dose of nonavalent vaccine given 3-8 years later - an exploratory study.

Gilca V, Sauvageau C, Panicker G, De Serres G, Ouakki M, Unger ER.

Hum Vaccin Immunother. 2019;15(2):503-507. doi: 10.1080/21645515.2018.1522469. Epub 2018 Sep 27.

11.

Overview of knowledge, attitudes, beliefs, vaccine hesitancy and vaccine acceptance among mothers of infants in Quebec, Canada.

Dubé È, Farrands A, Lemaitre T, Boulianne N, Sauvageau C, Boucher FD, Tapiero B, Quach C, Ouakki M, Gosselin V, Gagnon D, De Wals P, Petit G, Jacques MC, Gagneur A.

Hum Vaccin Immunother. 2019;15(1):113-120. doi: 10.1080/21645515.2018.1509647. Epub 2018 Sep 11.

12.

Early use of the HPV 2-dose vaccination schedule: Leveraging evidence to support policy for accelerated impact.

Gilca V, Salmerón-Castro J, Sauvageau C, Ogilvie G, Landry M, Naus M, Lazcano-Ponce E.

Vaccine. 2018 Aug 6;36(32 Pt A):4800-4805. doi: 10.1016/j.vaccine.2018.02.004. Epub 2018 Jun 7.

13.

Impact of the addition of new vaccines in the early childhood schedule on vaccine coverage by 24 months of age from 2006 to 2016 in Quebec, Canada.

Kiely M, Boulianne N, Talbot D, Ouakki M, Guay M, Landry M, Zafack J, Sauvageau C, De Serres G.

Vaccine. 2018 Jul 5;36(29):4383-4391. doi: 10.1016/j.vaccine.2018.03.085. Epub 2018 Jun 7.

PMID:
29887321
14.

NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy.

Roussy M, Bilodeau M, Jouan L, Tibout P, Laramée L, Lemyre E, Léveillé F, Tihy F, Cardin S, Sauvageau C, Couture F, Louis I, Choblet A, Patey N, Gendron P, Duval M, Teira P, Hébert J, Wilhelm BT, Choi JK, Gruber TA, Bittencourt H, Cellot S.

Genes Chromosomes Cancer. 2018 Jun;57(6):311-319. doi: 10.1002/gcc.22532. Epub 2018 Mar 28.

PMID:
29427526
15.

Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.

Goggin P, Sauvageau C, Gilca V, Defay F, Lambert G, Mathieu-C S, Guenoun J, Comète E, Coutlée F.

Hum Vaccin Immunother. 2018 Jan 2;14(1):118-123. doi: 10.1080/21645515.2017.1385688. Epub 2017 Dec 13.

16.

Absence of association between Guillain-Barré syndrome hospitalizations and HPV-vaccine.

Deceuninck G, Sauvageau C, Gilca V, Boulianne N, De Serres G.

Expert Rev Vaccines. 2018 Jan;17(1):99-102. doi: 10.1080/14760584.2018.1388168. Epub 2017 Oct 13.

PMID:
28972438
17.

Immunogenicity of 2 vs 3 Doses of the Quadrivalent Human Papillomavirus Vaccine in Girls Aged 9 to 13 Years After 60 Months.

Ogilvie G, Sauvageau C, Dionne M, McNeil S, Krajden M, Money D, Dobson S.

JAMA. 2017 Apr 25;317(16):1687-1688. doi: 10.1001/jama.2017.1840. No abstract available.

PMID:
28444267
18.

HPV vaccination for MSM: Synthesis of the evidence and recommendations from the Québec Immunization Committee.

Sauvageau C, Dufour-Turbis C.

Hum Vaccin Immunother. 2016 Jun 2;12(6):1560-5. doi: 10.1080/21645515.2015.1112474. Epub 2015 Nov 10. Review.

19.

Promoting vaccination: implementation of targeted interventions to enhance access to vaccination services in Quebec (Canada).

Dubé E, Gagnon D, Audet D, Bradet R, Boulianne N, Guay M, Sauvageau C.

Public Health. 2015 Dec;129(12):1627-9. doi: 10.1016/j.puhe.2015.07.013. Epub 2015 Sep 26. No abstract available.

PMID:
26390948
20.

The effect of a booster dose of quadrivalent or bivalent HPV vaccine when administered to girls previously vaccinated with two doses of quadrivalent HPV vaccine.

Gilca V, Sauvageau C, Boulianne N, De Serres G, Crajden M, Ouakki M, Trevisan A, Dionne M.

Hum Vaccin Immunother. 2015;11(3):732-8. doi: 10.1080/21645515.2015.1011570.

21.

"Nature Does Things Well, Why Should We Interfere?": Vaccine Hesitancy Among Mothers.

Dubé E, Vivion M, Sauvageau C, Gagneur A, Gagnon R, Guay M.

Qual Health Res. 2016 Feb;26(3):411-25. doi: 10.1177/1049732315573207. Epub 2015 Feb 23.

PMID:
25711847
22.

Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.

Gilca V, Sauvageau C, Boulianne N, De Serres G, Couillard M, Krajden M, Ouakki M, Murphy D, Trevisan A, Dionne M.

Hum Vaccin Immunother. 2014;10(8):2438-45. doi: 10.4161/hv.29617.

23.

Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study.

Laprise JF, Drolet M, Boily MC, Jit M, Sauvageau C, Franco EL, Lemieux-Mellouki P, Malagón T, Brisson M.

Vaccine. 2014 Oct 7;32(44):5845-53. doi: 10.1016/j.vaccine.2014.07.099. Epub 2014 Aug 12.

24.

Seasonal influenza vaccination uptake in Quebec, Canada, 2 years after the influenza A(H1N1) pandemic.

Dubé E, Gagnon D, Kiely M, Defay F, Guay M, Boulianne N, Sauvageau C, Landry M, Turmel B, Markowski F, Hudon N.

Am J Infect Control. 2014 May;42(5):e55-9. doi: 10.1016/j.ajic.2014.01.006.

PMID:
24773805
25.

Immunization services offered in Québec (Canada) pharmacies.

Sauvageau C, Dubé E, Bradet R, Mondor M, Lavoie F, Moisan J.

Hum Vaccin Immunother. 2013 Sep;9(9):1943-9. doi: 10.4161/hv.25186. Epub 2013 Jun 19.

26.

[Knowledge and attitudes toward vaccination among midwives in Quebec].

Dubé E, Vivion M, Valderrama A, Sauvageau C.

Sante Publique. 2013 Jan-Feb;25(1):35-43. French.

PMID:
23705333
27.

Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.

Dobson SR, McNeil S, Dionne M, Dawar M, Ogilvie G, Krajden M, Sauvageau C, Scheifele DW, Kollmann TR, Halperin SA, Langley JM, Bettinger JA, Singer J, Money D, Miller D, Naus M, Marra F, Young E.

JAMA. 2013 May 1;309(17):1793-802. doi: 10.1001/jama.2013.1625.

PMID:
23632723
28.

Factors associated with HPV vaccination among adult women in Quebec.

Kiely M, Sauvageau C, Dubé E, Deceuninck G, De Wals P.

Hum Vaccin Immunother. 2013 Jul;9(7):1421-4. doi: 10.4161/hv.24603. Epub 2013 Apr 9.

29.

How do Midwives and Physicians Discuss Childhood Vaccination with Parents?

Dubé E, Vivion M, Sauvageau C, Gagneur A, Gagnon R, Guay M.

J Clin Med. 2013 Nov 4;2(4):242-59. doi: 10.3390/jcm2040242.

30.

Determinants of parents' decision to vaccinate their children against rotavirus: results of a longitudinal study.

Dubé E, Bettinger JA, Halperin B, Bradet R, Lavoie F, Sauvageau C, Gilca V, Boulianne N.

Health Educ Res. 2012 Dec;27(6):1069-80. doi: 10.1093/her/cys088. Epub 2012 Aug 20.

PMID:
22907535
31.

Removal of microcystin-LR from spiked water using either activated carbon or anthracite as filter material.

Drogui P, Daghrir R, Simard MC, Sauvageau C, Blais JF.

Environ Technol. 2012 Feb-Mar;33(4-6):381-91.

PMID:
22629609
32.

Clinicians' opinions on new vaccination programs implementation.

Dubé E, Gilca V, Sauvageau C, Bettinger JA, Boucher FD, McNeil S, Gemmill I, Lavoie F, Ouakki M, Boulianne N.

Vaccine. 2012 Jun 29;30(31):4632-7. doi: 10.1016/j.vaccine.2012.04.100. Epub 2012 May 11.

PMID:
22580354
33.

[Seasonal H1N1: a worry on the competence, attitude and practices of nurses during the vaccination campaign].

Kiely M, Defay F, Sauvageau C, Gilca V, Guay M, Boulianne N, Dubé E.

Perspect Infirm. 2012 Jan-Feb;9(1):61-4. French. No abstract available.

PMID:
22295461
34.

Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.

Gilca V, De Serres G, Hamelin ME, Boivin G, Ouakki M, Boulianne N, Sauvageau C, Dionne M, Gilca R, Skowronski D.

Vaccine. 2011 Dec 9;30(1):35-41. doi: 10.1016/j.vaccine.2011.10.062. Epub 2011 Nov 7.

PMID:
22063386
35.

Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children.

Gilca R, Deceuninck G, De Serres G, Boulianne N, Sauvageau C, Quach C, Boucher FD, Skowronski DM.

Pediatrics. 2011 Nov;128(5):e1084-91. doi: 10.1542/peds.2010-3492. Epub 2011 Oct 10.

PMID:
21987710
36.

[Human papilloma virus: knowledge, beliefs and behavior of Quebec women].

Kiely M, Sauvageau C, Dubé E, Deceuninck G, De Wals P.

Can J Public Health. 2011 Jul-Aug;102(4):303-7. French.

PMID:
21913589
37.

Acute otitis media and its prevention by immunization: a survey of Canadian pediatricians' knowledge, attitudes and beliefs.

Dubé E, Gilca V, Sauvageau C, Bradet R, Lavoie F, Boulianne N, Boucher FD, Bettinger JA, McNeil S, Gemmill I.

Hum Vaccin. 2011 Apr;7(4):429-35. Epub 2011 Apr 1.

PMID:
21441777
38.

Canadian paediatricians' opinions on rotavirus vaccination.

Dubé E, Gilca V, Sauvageau C, Bradet R, Bettinger JA, Boulianne N, Boucher FD, McNeil S, Gemmill I, Lavoie F.

Vaccine. 2011 Apr 12;29(17):3177-82. doi: 10.1016/j.vaccine.2011.02.044. Epub 2011 Mar 2.

PMID:
21376118
39.

Feasibility and impact of providing feedback to vaccinating medical clinics: evaluating a public health intervention.

Brousseau N, Sauvageau C, Ouakki M, Audet D, Kiely M, Couture C, Paré A, Deceuninck G.

BMC Public Health. 2010 Dec 3;10:750. doi: 10.1186/1471-2458-10-750.

40.

[Human papillomavirus vaccination program].

Sauvageau C, Kiely M.

Perspect Infirm. 2010 Jul-Aug;7(4):50-2. French. No abstract available.

PMID:
20653316
41.

Canadian family physicians' and paediatricians' knowledge, attitudes and practices regarding A(H1N1) pandemic vaccine.

Dubé E, Gilca V, Sauvageau C, Boulianne N, Boucher FD, Bettinger JA, McNeil S, Gemmill I, Lavoie F, Ouakki M.

BMC Res Notes. 2010 Apr 14;3:102. doi: 10.1186/1756-0500-3-102.

42.

Adult immunization services: steps have to be done.

Huot C, Sauvageau C, Tremblay G, Dubé E, Ouakki M.

Vaccine. 2010 Feb 3;28(5):1177-80. doi: 10.1016/j.vaccine.2009.11.038. Epub 2009 Nov 27.

PMID:
19945413
43.

Attitudes of nurses toward current and proposed vaccines for public programs: a questionnaire survey.

Gilca V, Boulianne N, Dubé E, Sauvageau C, Ouakki M.

Int J Nurs Stud. 2009 Sep;46(9):1219-35. doi: 10.1016/j.ijnurstu.2009.02.013. Epub 2009 Apr 5.

PMID:
19349047
44.

[Vaccination against human papillomaviruses].

Duval B, Sauvageau C, Boulianne N, Gilca V; Comité sur l'immunisation du Québec.

Perspect Infirm. 2009 Jan-Feb;6(1):49-50, 52; quiz 46, 52. French. No abstract available.

PMID:
19341056
45.

Cervical cancer prevention by vaccination: nurses' knowledge, attitudes and intentions.

Duval B, Gilca V, Boulianne N, Pielak K, Halperin B, Simpson MA, Sauvageau C, Ouakki M, Dube E, Lavoie F.

J Adv Nurs. 2009 Mar;65(3):499-508. doi: 10.1111/j.1365-2648.2008.04900.x.

PMID:
19222647
46.

[Factors determining utilization of a Web site by parents in order to report side effects of vaccines].

Kimpton A, Dubé E, Sauvageau C, De Serres G.

Can J Public Health. 2008 Nov-Dec;99(6):456-9. French.

PMID:
19149385
47.

Setting priorities for new vaccination programs by using public health officers and immunization managers opinions.

Gilca V, Sauvageau C, McNeil S, Gemmill IM, Dionne M, Dobson S, Ouakki M, Lavoie F, Duval B.

Vaccine. 2008 Aug 5;26(33):4204-9. doi: 10.1016/j.vaccine.2008.05.061. Epub 2008 Jun 11.

PMID:
18582998
48.

[Do you counsel your patients on their health behaviors?].

Sauvageau C, Groulx S, Pelletier A, Ouakki M, Dubé E.

Can J Public Health. 2008 Jan-Feb;99(1):31-5. French.

PMID:
18435387
49.

Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada.

Sauvageau C, Duval B, Gilca V, Lavoie F, Ouakki M.

BMC Public Health. 2007 Oct 25;7:304.

50.

Vaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs.

Duval B, Gilca V, McNeil S, Dobson S, Money D, Gemmill IM, Sauvageau C, Lavoie F, Ouakki M.

Vaccine. 2007 Nov 7;25(45):7841-7. Epub 2007 Sep 14.

PMID:
17923173

Supplemental Content

Loading ...
Support Center